{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:40:40Z","timestamp":1792172440346,"version":"4.4.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jocn.2015.04.014","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T17:21:45Z","timestamp":1437067305000},"page":"1830-1832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Propofol as a substitute for amobarbital in Wada testing"],"prefix":"10.1016","volume":"22","author":[{"given":"Albert Ho Yuen","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bynevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejinder Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2015.04.014_b0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1345\/aph.1P476","article-title":"Alternatives to sodium amobarbital in the Wada test","volume":"45","author":"Patel","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jocn.2015.04.014_b0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF03012106","article-title":"Propofol administered via the carotid artery to achieve a Wada test","volume":"45","author":"Bazin","year":"1998","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jocn.2015.04.014_b0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/01.WNL.0000133199.65776.18","article-title":"Intracarotid propofol test for speech and memory dominance in man","volume":"63","author":"Takayama","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2015.04.014_b0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.yebeh.2008.12.023","article-title":"Intracarotid propofol testing: a comparative study with amobarbital","volume":"14","author":"Mikati","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocn.2015.04.014_b0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3174\/ajnr.A1855","article-title":"Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures","volume":"31","author":"Feliciano","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2015.04.014_b0030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1212\/01.wnl.0000176988.87336.ff","article-title":"Evaluation of adverse effects in intracarotid propofol injection for Wada test","volume":"65","author":"Mikuni","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2015.04.014_b0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2176\/nmc.50.622","article-title":"Intravenous methylprednisolone reduces the risk of propofol-induced adverse effects during Wada testing","volume":"50","author":"Mikuni","year":"2010","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.jocn.2015.04.014_b0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.seizure.2013.10.009","article-title":"Bilateral Wada test: amobarbital or propofol?","volume":"23","author":"Curot","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2015.04.014_b0045","first-page":"218","article-title":"Tolerability of propofol in Wada testing","volume":"19","author":"Alsallom","year":"2014","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.jocn.2015.04.014_b0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.seizure.2012.02.001","article-title":"A comparison of propofol and amobarbital for use in the Wada test","volume":"21","author":"Magee","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2015.04.014_b0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/bja\/aen346","article-title":"Efficacy of intracarotid propofol infusion and impact of cerebral blood flow alteration","volume":"102","author":"Lao","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jocn.2015.04.014_b0060","unstructured":"MIMS Australia. MIMS Online. Hp. Online Available: https:\/\/www-mimsonline-com-au.qelibresources.health.wa.gov.au\/Search\/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=diprivan&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=19000001_2 [accessed 08.12.14]."},{"key":"10.1016\/j.jocn.2015.04.014_b0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.wneu.2010.10.048","article-title":"Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance","volume":"75","author":"Fujii","year":"2011","journal-title":"World Neurosurg"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815003197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815003197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T22:51:23Z","timestamp":1537483883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586815003197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0967586815003197"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2015.04.014","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propofol as a substitute for amobarbital in Wada testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2015.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}